E-therapeutics Plc
ETXPF · OTC
1/31/2025 | 7/31/2024 | 1/31/2024 | 7/31/2023 | |
|---|---|---|---|---|
| Market Cap | – | $71,138 | $95,565 | $131,609 |
| - Cash | $20,519 | $41,043 | $20,665 | $24,845 |
| + Debt | $0 | $521 | $710 | $90 |
| Enterprise Value | – | $30,616 | $75,610 | $106,854 |
| Revenue | $0 | $0 | $158 | $160 |
| % Growth | – | -100% | -1% | – |
| Gross Profit | $0 | -$267 | -$106 | -$111 |
| % Margin | – | – | -67.1% | -69.4% |
| EBITDA | -$11,220 | -$7,254 | -$6,169 | -$6,348 |
| % Margin | – | – | -3,900.6% | -3,972.5% |
| Net Income | -$8,607 | -$6,286 | -$5,577 | -$5,587 |
| % Margin | – | – | -3,526.6% | -3,496.2% |
| EPS Diluted | -0.011 | -0.011 | -0.01 | -0.01 |
| % Growth | 2.6% | -19.4% | 0.2% | – |
| Operating Cash Flow | -$8,602 | -$7,738 | -$3,639 | -$6,539 |
| Capital Expenditures | -$36 | -$374 | -$373 | -$108 |
| Free Cash Flow | -$8,638 | -$8,113 | -$4,013 | -$6,647 |